Why the study?
Does selective slow pathway ablation using a midseptal approach achieve high procedural success and low recurrence in patients with inducible AVNRT?
Population
60 consecutive patients with inducible AV nodal reentrant tachycardia (AVNRT)
Design
Cohort
Follow-up
mean 20.1 +/- 0.6 months (11.5-28 months)
Authors
Loading...
Supports midseptal ablation for AVNRT; leaves open need for randomized trials on durability and generalizability.
Does selective slow pathway ablation using a midseptal approach achieve high procedural success and low recurrence in patients with inducible AVNRT?
A direct midseptal approach for selective slow pathway ablation in AVNRT is highly successful (98%) and safe, though residual slow pathway conduction is associated with a higher rate of recurrence.
Epstein et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: